scispace - formally typeset
E

Estefanía Rodríguez

Researcher at Bernhard Nocht Institute for Tropical Medicine

Publications -  35
Citations -  1593

Estefanía Rodríguez is an academic researcher from Bernhard Nocht Institute for Tropical Medicine. The author has contributed to research in topics: Ebola virus & Virus. The author has an hindex of 17, co-authored 31 publications receiving 1057 citations. Previous affiliations of Estefanía Rodríguez include Icahn School of Medicine at Mount Sinai & Leibniz Association.

Papers
More filters
Journal ArticleDOI

Animal models for COVID-19.

César Muñoz-Fontela, +64 more
- 23 Sep 2020 - 
TL;DR: The findings of a World Health Organization expert working group that is developing animal models to test vaccines and therapeutic agents for the treatment of COVID-19, and their relevance for preclinical testing, are reviewed.
Journal ArticleDOI

The sequential activation of the yeast HOG and SLT2 pathways is required for cell survival to cell wall stress.

TL;DR: Both MAPK pathways are essential for cell survival under these circumstances because mutant strains deficient in different components of both pathways are hypersensitive to zymolyase.
Journal ArticleDOI

Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study.

TL;DR: Using the biostatistical model, it is predicted that 50% and 90% of male survivors clear Ebola virus RNA from seminal fluid at 115 days (90% prediction interval 72-160) and 294 days (212-399) after disease onset, respectively, and the number of men positive for Ebola virusRNA in affected countries would decrease from about 50 in January 2016, to fewer than 1 person by July, 2016.
Journal ArticleDOI

A functional role for KLF6-SV1 in lung adenocarcinoma prognosis and chemotherapy response.

TL;DR: It is shown that increased expression of KLF6-SV1 is associated with decreased survival in patients with lung adenocarcinoma, and targeted reduction of KLFsV1 using siRNA induces apoptosis both alone and in combination with the chemotherapeutic drug cisplatin.